Nuvectis Pharma's total assets for Q1 2025 were $30.15M, an increase of 62.03% from the previous quarter. NVCT total liabilities were $9.19M for the fiscal quarter, a 3.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.